Aktive Positionen von Bryan Fedorak
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Bartesian, Inc.
 Bartesian, Inc. Industrial MachineryProducer Manufacturing Bartesian, Inc. engages in the creation of cocktail drinks business. It offers capsule drink-maker such as vodka, rum, tequila, margarita, and gin. The company was founded by Bryan Fedorak and Ryan Close and is headquartered in Kitchener, Canada. | Gründer | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | - | - | |
| Vorstandsvorsitzender | - | - | |
Metabolomic Technologies, Inc.
 Metabolomic Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Metabolomic Technologies, Inc. is a Canadian company that specializes in developing in vitro diagnostics using metabolomics. Metabolomic Technologies was founded by Haili Wang and Richard Fedorak and is based in Edmonton, CA. The company's lead product, PolypDX™, is a urine-based screening test for colorectal cancer. The company utilizes a unique metabolomics platform to identify distinct metabolic fingerprints and develop accurate diagnostic tests. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Bryan Fedorak
Statistik
International
| Kanada | 3 |
Operativ
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sektoral
| Producer Manufacturing | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Bartesian, Inc.
Bartesian, Inc. Industrial MachineryProducer Manufacturing Bartesian, Inc. engages in the creation of cocktail drinks business. It offers capsule drink-maker such as vodka, rum, tequila, margarita, and gin. The company was founded by Bryan Fedorak and Ryan Close and is headquartered in Kitchener, Canada. | Producer Manufacturing |
Metabolomic Technologies, Inc.
Metabolomic Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Metabolomic Technologies, Inc. is a Canadian company that specializes in developing in vitro diagnostics using metabolomics. Metabolomic Technologies was founded by Haili Wang and Richard Fedorak and is based in Edmonton, CA. The company's lead product, PolypDX™, is a urine-based screening test for colorectal cancer. The company utilizes a unique metabolomics platform to identify distinct metabolic fingerprints and develop accurate diagnostic tests. | Commercial Services |
- Börse
- Insiders
- Bryan Fedorak
- Erfahrung
